ASLAN Pharmaceuticals Ltd (ASLN) Earnings History & Surprises
NASDAQ:ASLN • US04522R2004
0.6 USD
-0.1 (-14.27%)
At close: Jul 18, 2024
0.56 USD
-0.04 (-6.67%)
After Hours: 7/18/2024, 8:00:00 PM
Past quarterly earnings results for ASLAN Pharmaceuticals Ltd (ASLN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateAug 9, 2024
PeriodQ2 / 2024
EPS Estimate-$3.67
Revenue Estimate
Last Reported
Release DateMay 31, 2024
PeriodQ1 / 2024
EPS Reported-$4.24
EPS Surprise 14.82%
Revenue Surprise %
Beat Rate
31%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2024 | -4.24 | -4.98 | 14.82% | -228.68% | - | - | ||
| Q4 2023 | -6.24 | -5.30 | -17.65% | -500.00% | - | - | ||
| Q3 2023 | -0.56 | -0.80 | 29.61% | 30.00% | - | - | ||
| Q2 2023 | -0.11 | -0.82 | 86.52% | 88.42% | 12M | - | - | |
| Q1 2023 | -1.29 | -4.13 | 68.77% | -35.79% | - | - | ||
| Q4 2022 | -1.04 | -0.91 | -14.56% | -30.00% | - | - | ||
| Q3 2022 | -0.80 | -0.97 | 17.44% | -566.67% | - | - | ||
| Q2 2022 | -0.95 | -1.02 | 6.86% | -1,257.14% | - | - | ||
| Q1 2022 | -0.95 | -0.92 | -3.49% | -630.77% | - | - | ||
| Q4 2021 | -0.80 | -0.73 | -9.44% | -433.33% | - | - | ||
| Q3 2021 | -0.12 | -0.13 | 9.50% | -20.00% | - | - | ||
| Q2 2021 | -0.07 | -0.11 | 37.61% | 32.69% | - | - | ||
| Q1 2021 | -0.13 | -0.11 | -15.86% | -30.00% | - | - | ||
| Q4 2020 | -0.15 | -0.10 | -47.06% | - | - | - | ||
| Q3 2020 | -0.10 | -0.10 | -3.20% | - | - | - | ||
| Q2 2020 | -0.10 | -0.08 | -27.45% | - | - | - | ||
| Q1 2020 | -0.10 | -0.08 | -22.55% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
39.54%
Max EPS beat (4)
86.52%
Min EPS beat (4)
-14.56%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, ASLN has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, ASLN has beaten the EPS estimates by 39.5% on average.
ASLAN Pharmaceuticals Ltd / ASLN Earnings FAQ
What is the most recent earnings date for ASLN stock?
ASLAN Pharmaceuticals Ltd (ASLN) last reported earnings on 5/31/2024.
Did ASLAN Pharmaceuticals Ltd (ASLN) beat earnings estimates last quarter?
ASLAN Pharmaceuticals Ltd (ASLN) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does ASLN stock beat earnings estimates?
In the last 4 quarters, ASLAN Pharmaceuticals Ltd (ASLN) has beaten EPS estimates in 3 out of 4 releases.